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Commentary
Nanotechnology is currently one of the fastest
growing technical ﬁelds that develops meth-
ods for the design, production, and applica-
tions for materials and devices ≤ 100 nm in
size. There are numerous potential applica-
tions arising from nanotechnology which
include their use in aerospace, agriculture,
security, energy, information technology,
medicine, transportation, consumer products,
and environmental improvement (Nanoscale
Science 2004). Nanotechnology is projected
to be a US$ 1 trillion industry by 2015 (Nel
et al. 2006).
Nanoparticles are particles that have one 
or more dimensions ≤ 100 nm [Scientific
Committee on Emerging and Newly Identiﬁed
Health Risks (SCENIHR) 2005]. Because of
their small size, much concern has been
expressed about the potential for adverse health
effects arising from the ability of nanoparticles
to penetrate cell walls and the blood–brain bar-
rier. These concerns include possible detrimen-
tal health effects during manufacture and
transport as well as their fate and transport in
the environment [United Kingdom Royal
Society 2004; U.S. Environmental Protection
Agency (U.S. EPA) 2005]. At this time there are
no occupational health and safety guidelines for
production and use of these nano products.
This concern over lack of guidelines has resulted
in a coordinated collaborative effort between
several U.S. agencies—the National Institutes of
Health, the National Toxicology Program head-
quartered at the National Institute of
Environmental Health Sciences, the U.S. EPA,
the Centers for Disease Control and Prevention,
the National Institute for Occupational Safety
and Health, and the Occupational Safety and
Health Administration—and comprehensive
reports by The Royal Society and the Royal
Academy of Engineering of the United
Kingdom (2004), a European Commission
report (SCENIHR 2005), and a White paper
from the U.S. EPA (2005). These efforts
address several additional critical issues that
include the lack of standardization of materi-
als available for conﬁrmatory product evalua-
tion, monitoring in the workplace and
environment, and testing procedures.
Some of the major industries using or
planning to use nanotechnology manufactured
goods include electronics, personal care prod-
ucts, and metal and ceramic manufacturers. By
design, many of the nanotechnology products
in development or in use contain a metal (or
metalloid in the case of arsenic) (Table 1). We
suggest that many of the concerns outlined
above can be addressed with the approach of
isotopic tracing, whereby a stable isotope of the
element of interest is incorporated into the
product, allowing any transfer to be easily
detected using inductively coupled mass spec-
trometry (ICP-MS), high resolution ICP-MS,
multi-collector ICP-MS, or thermal ionization
MS (TIMS). This approach differs from trac-
ing using radiolabeled metals, such as 64Cu,
which generally have a short half-life (Michalet
et al. 2005)
Stable Isotope Tracing
For several decades, stable isotope tracing has
been used widely in the earth sciences, such as
understanding the origin of rocks and in envi-
ronmental applications. This technique also has
been applied in nutritional and metabolic bal-
ance studies and health investigations (Gulson
1996). In this commentary, we use the term
“stable” for metal isotopes rather than its com-
mon application to the light-stable isotopes of
hydrogen, carbon, nitrogen and sulfur.
There are two main approaches in the use
of isotope tracing, one based on naturally
occurring differences between stable isotopes
and the other that uses the addition of a
tracer of the separated isotope.
The ﬁrst approach uses variations in iso-
topic abundance of the stable end products
arising from radioactive decay. For example,
the stable end products of lead-206 (206Pb),
207Pb, and 208Pb, are derived by long-term
radioactive decay of parents uranium-238
(238U), 235U, and thorium-232, respectively.
The fourth lead isotope, 204Pb, has no known
radioactive parent. Hence, over geologic time,
lead forms into mineral deposits that have
major differences in isotopic composition,
that can accumulate in the bones of the
inhabitants. Such naturally occurring isotopic
differences have been used in recent investi-
gations of the mobilization of lead from the
maternal skeleton during pregnancy and lacta-
tion (Gulson et al. 1997, 1998, 2004; Manton
et al. 2003). In the Australian study (Gulson
et al. 1997, 1998, 2004), investigators exam-
ined a) differences in the lead isotopic signa-
ture of long-term Australian residents and the
environment exposed to geologically old mine
lead formed > 1.7 billion years ago, and b) the
signature in migrants to Australia who were
generally exposed to geologically young lead
formed approximately 300–400 million years
ago. By monitoring blood and urine lead iso-
topic values during pregnancy and lactation
and comparing these isotopic values with those
in the environment (diet, air, water, soil, dust),
it was possible to estimate the extra amount of
lead coming from the maternal skeleton.
Similarly, variations in the four isotopes of
strontium (84Sr, 86Sr, 87Sr, 88Sr) have been
used to investigate migration paths and dietary
habits of humans and animals (Beard and
Johnson 2000).
The second approach applies to elements
that do not have a radioactive parent. In this
case, there are negligible or very small variations
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in natural abundance between the different
isotopes. To trace such elements, a stable non-
radioactive isotope or tracer whose abundance
is different from that occurring naturally is
incorporated into the product. Many tracers
are available from commercial suppliers and
their price usually depends on the natural
abundance, with the lower the natural abun-
dance the higher the cost. This technique can
be applied easily for some of the elements and
compounds currently being designed or used
as nanoparticles (Table 1). Where possible, if
not cost-prohibitive, the tracer can be added
to enhance the isotopic abundance to show a
difference from that occurring naturally, thus
making it easier to detect in a study. The abil-
ity to detect differences depends on a number
of factors, including the purity of the sepa-
rated tracer, the total amount of the element
under investigation, and the sensitivity of the
instruments for measuring the isotopic abun-
dances. For example, TIMS is considered to
be the “gold standard” for isotopic measure-
ments although multi-collector ICP-MS or
high-resolution ICP-MS may also be suitable,
depending on conditions. This approach has
been used widely in nutritional and metabolic
balance studies [see references up to 1995 in
Gulson (1996)] and pharmacokinetic investi-
gations of, for example, lead in humans
(Rabinowitz et al. 1976) and cynomolgous
monkeys (Franklin et al. 1997).
Possible Uses for Isotopic
Tracing in Nanotechnology
The second approach, which uses isotopic trac-
ers and is described in the previous section,
offers the greatest potential for use in nanotech-
nology. For example, zinc oxide (ZnO) and
titanium dioxide (TiO)nanoparticles are being
used in sunscreens and other personal care
products. Zinc has ﬁve isotopes whose naturally
occurring abundances are listed in Table 1.
68Zn with a natural abundance of 18.6% is the
isotope of choice for studies of zinc oxide
because of cost considerations. We are conduct-
ing investigations using 68Zn and 46Ti as tracers
in sunscreen products containing zinc oxide
and titanium dioxide to determine in vivo their
dermal absorption and excretion in humans.
Use of zinc isotopes is not just limited to
sunscreen nanoparticles, as zinc is found in sev-
eral other nanoparticles such as quantum dots.
Quantum dots are crystals of semiconductor
compounds [e.g., cadmium selenide (CdSe),
lead sulﬁde] with a diameter between 2- and
10-nm wide or 10 and 50 atoms, respectively,
and have a range of useful electrical and optical
properties that diverge in character from those
of bulk material (Evident Technologies Inc.
2006). For example, quantum dots are being
researched as potential artiﬁcial ﬂuorophores
for detection of tumors, using fluorescence
spectroscopy. In one product being developed,
the metals giving rise to the fluorescence of
CdSe or cadmium telluride (CdTe), have a
coating of zinc sulﬁde to minimize exposure to
the highly toxic Cd and potentially toxic Se or
Te. There is concern that the coating may
degrade before the quantum dots are excreted
from the body, but apart the data from mice
and cellular studies, there are no human data
(Derfus et al. 2004; Lovric et al. 2005). The
integrity of the coating could be monitored by
using either a single isotopic tracer such as 68Zn
incorporated into the coating or an “overkill”
that could employ a multiple isotopic approach,
as Cd has eight naturally occurring isotopes, Se
has six, Te has eight, and Zn has ﬁve (Table 1).
Stable isotope tracing for monitoring
exposures to nanoproducts has many poten-
tial uses, including incorporation of a tracer
in the production process to monitor worker
exposure. The exposure can be monitored
from isotopic measurements of wipes from
areas such as protective clothing, hands, and
face, or collection of biomarkers such as blood
and urine. Furthermore, simple surface wipes
and/or dust accumulation methods using
petri dishes could be used for air monitoring
exposures, followed by isotopic analysis.
In addition to the occupational aspects,
concerns over fate and transport of nanoparti-
cles in the environment (U.S. EPA 2005) and
pharmacokinetic modeling and cytotoxicity
studies such as those undertaken by the
National Toxicology Program (Walker 2006)
also could be addressed using the isotopic
approach.
Conclusions
We suggest that the stable isotope tracing
approach has enormous capability to address
many of the current concerns (noted in the
introduction) being raised by scientiﬁc bodies.
The stable isotope tracing approach has many
advantages for use for monitoring purposes in
the nanotechnology ﬁeld, including a) many of
the metals/metalloids currently used in nano-
technology have more than one isotope, and
this approach can be readily implemented;
b) the stable, usually high-purity, isotopes used
in such studies are nonradioactive; c) the stable
isotopes do not have the disadvantage of
radioactive tracers which commonly have very
short half-lives and may give low radiation
doses, and thus allow long-term monitoring;
and d) the methods for isotopic measurements
of ICP-MS and TIMS are applicable to most
metals and are routinely used in environmental
and health investigations. While the initial
investment to obtain the isotopic tracers may
be high, the dividends of providing reliable sci-
entific evaluations for monitoring these
nanoparticles in environmental and biological
systems will more than offset the initial cost.
Table 1. Some products used in nanotechnology and their natural relative isotopic abundances.
Product Symbol Isotope and natural relative abundances (%) 
Cadmium sulﬁde CdS Cd: 106 (1.2), 108 (0.9), 110 (12.4), 111 (12.8), 112 (24.0), 113 (12.3), 114 (28.8), 116 (7.6)
S: 32 (95.0), 33 (0.75), 34 (4.2), 36 (0.02)
Cadmium selenide CdSe Se: 74 (0.9), 76 (9.0), 77 (7.5), 78 (23.5), 80 (50), 82 (9)
Cadmium telluride CdTe Te: 120 (0.09), 122 (2.4), 123 (0.87), 124 (4.6), 125 (7.0), 126 (18.7), 128 (31.8), 130 (34.5)
Calcium Ca Ca: 40 (96.9), 42 (0.65), 43 (0.14), 44 (2.08), 46 (0.003), 48 (0.19)
Chromium Cr Cr: 50 (4.35), 52 (83.8), 53 (9.5), 54 (2.36)
Iron Fe Fe: 54 (5.8), 56 (91.7), 57 (2.14), 58 (0.31)
Gallium phosphide/arsenide GaP/As Ga: 69 (60), 71 (40)
Gallium antimonide/selenide/telluride GaSb/Se/Te Sb:121 (57.3), 123 (42.7)
Indium phosphide/arsenide/antimonide InP/As/Sb In: 113 (4.3), 115 (95.7)
Lead sulﬁde/selenide/telluride PbS/Se/Te Pb: 204 (1.4), 206 (24.1), 207 (22.1), 208 (52.4)
Magnesium Mg Mg: 24 (79), 25 (10), 26 (11)
Molydenum Mo Mo: 92 (14.8), 94 (9.1), 95 (15.9), 96 (16.7), 97 (9.5), 98 (24.4)
Silicon germanium/carbide SiGe/C Si: 28 (92.2), 29 (4.7), 30 (3.1);Ge: 70 (20.7), 72 (27.5), 73 (7.7), 74 (36.4), 76 (7.7)
Tantalum Ta Ta: 180 (0.01), 181 (99.9)
Silver Ag Ag: 107 (51.4), 109 (48.7)
Titanium dioxide TiO2 Ti: 46 (8.0), 47 (7.5), 48 (73.7), 49 (5.5), 50 (5.3)
Tungsten W W: 180 (0.13), 182 (26.3), 183 (14.3), 184 (30.7), 186 (28.6)
Vanadium V V: 50 (0.25), 51 (99.7)
Zinc oxide/sulﬁde/selenide/telluride ZnO/S/Se/Te Zn: 64 (48.9), 66 (27.8), 67 (4.1), 68 (18.6), 70 (0.62)
Zirconium Zr Zr: 90 (51.4), 91 (11.2), 92 (17.1), 94 (17.5), 96 (2.8)Gulson and Wong
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